MediciNova Inc. announced it will present data from its ongoing clinical trial evaluating MN-166 (ibudilast) in both early and advanced stage amyotrophic lateral sclerosis (ALS) patients at the 68th Annual Meeting of the American Academy of Neurology (AAN) April 15-21 at the Vancouver Convention Centre in Vancouver, Canada.
In this Channel 4 News video, Stephen Hawking talks about the documentary he both wrote and narrated, which traces his life from childhood to the present day. “It also covers his struggle with motor neurone disease and the toll that has taken on his personal relationships.” Learn more…
Engaging with the recent debate on the assisted dying bill in the UK, this BBC Two documentary shows the real story of Simon Binner. As BBC describes it: “The dramatic and poignant story of one man facing the heartwrenching decision of whether to end his life at a suicide…
The ALS Finding a Cure Foundation and the ALS Association are partnering for the Grand Challenge, an initiative to develop a biomarker to track TDP43 aggregation — the primary protein aggregate found in the brain and spinal cord of people with amyotrophic lateral sclerosis (ALS). The winning team,…
In this 2014 TEDTalk, Siddharthan Chandran speaks about brain injury and the possibility of using special brain stem cells in new therapeutical approaches. Read more about ALS here: https://bit.ly/1QHMBGw…
Last week’s hot topic on ALS was an article titled ALS Link to Veterans of Persian Gulf War Suggested Again in US Government Report, written by Magdalena Kegel. U.S. veterans who fought in the Persian Gulf War of 1990-91 appear to be…
The ALS Association has announced its new Translational Research Advancing Therapy for ALS (TREAT ALS) Drug Development Contract grant program, which will fund research for the development of new treatments for amyotrophic lateral sclerosis (ALS). According to a press release, the program will support research from early target identification…
Simplesa, a nutrition company established in 2013 after the amyotrophic lateral sclerosis (ALS) community showed its support for its metabolic supplement called the Deanna Protocol, or DP diet, has expanded the Deanna Protocol Bundle Pack choices for consumers. The Deanna Protocol is an all-natural metabolic program developed by Dr. Vincent Tedone, a…
U.S. veterans who fought in the Persian Gulf War of 1990-91 appear to be at an increased risk for amyotrophic lateral sclerosis (ALS), according to report from the Institute of Medicine (IOM) of the National Academies of Sciences, Engineering, and Medicine. The U.S. Department of Veterans Affairs had requested the review, evaluating and summarizing…
A recent paper from French researchers questions one of the primary ideas about what causes amyotrophic lateral sclerosis (ALS), and proposes that overactive nervous system cells are not a primary cause of the neurodegenerative disease. The paper, titled “Is hyperexcitability really guilty in amyotrophic lateral sclerosis?” appeared in…
Get regular updates to your inbox.
